Skip to main content
ImmuneCited

Vitamin D için Immune Aging (Immunosenescence)

B

Research suggests vitamin D supplementation in elderly populations may help improve immune markers and vaccine response. Deficiency is highly prevalent in older adults and is associated with impaired immune function and increased infection susceptibility.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dimmunosenescence'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Sonuç

Research suggests vitamin D supplementation in elderly populations may help improve immune markers and vaccine response. Deficiency is highly prevalent in older adults and is associated with impaired immune function and increased infection susceptibility.

Key Study Findings

Review
Fanconi anaemia as a human model of accelerated epigenetic and immune ageing.
Dose: None vs: None Outcome: None Etki: None None

Popülasyon: patients with Fanconi anaemia

Randomized Controlled Trial n=124
Effects of a Novel Dispersible Supplement Containing 2500 IU of Vitamin D and 1000 µg …
Dose: 2500 IU vitamin D + 1000 mcg B12 vs: Separate D+B12 and no supplementation control Outcome: Serum 25-OH-D and B12 level restoration Etki: 37.1% adequate vs 29.4% separate None

Popülasyon: Adults with vitamin D (<20ng/mL) and B12 (<250ng/L) insufficiency

Observational Study n=72
Cardiovascular Risk and Systemic Inflammation in Alopecia Areata: An Observational Case-control Study.
Dose: None vs: Healthy controls Outcome: CVR and systemic inflammation in alopecia areata Etki: None None

Popülasyon: 36 AA patients vs 36 matched controls, mean age 39

Controlled Clinical Trial
Vitamin D stimulates Il-15 synthesis in rodent muscle.
Dose: Single dose (rats); variable (in vitro) vs: Untreated controls; VDR-KO mice Outcome: IL-15 gene expression in skeletal muscle Etki: None None

Popülasyon: C2C12 myotubes, rats, VDR-KO mice

Randomized Controlled Trial 8 weeks
Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus …
Dose: Topical ointment application (3 arms) vs: 3-arm: mometasone vs calcipotriol vs tacrolimus Outcome: SALT score change at 8 weeks Etki: None <0.001 (momet, calcipot)

Popülasyon: Patients with localized alopecia areata

Other
Modelling the influence of vitamin D and probiotics on inflammation and the intestinal microbiota in …
Dose: None vs: No supplementation (modeled) Outcome: Epithelial barrier integrity and immune response Etki: None None

Popülasyon: Older adults (mathematical model)

Key Statistics

10

Çalışmalar

5000

Katılımcılar

Positive

B

Derece

Referenced Papers

Biochemistry and biophysics … 2025
International journal of … 2023 54 atıf
Autoimmunity reviews 2023 24 atıf
Physiological research 2021 2 atıf
Advances in chronic … 2019 326 atıf
Actas dermo-sifiliograficas 2019 43 atıf
Postepy dermatologii i … 2017 31 atıf
World journal of … 2016 238 atıf
Ageing research reviews 2016 142 atıf
Postepy dermatologii i … 2016 59 atıf
Indian dermatology online … 2016 51 atıf
World journal of … 2015 62 atıf
The American journal … 2014 125 atıf
European journal of … 2012 225 atıf
Inflammatory bowel diseases 2012 224 atıf
Gerontology 2011 27 atıf
Gastroenterology 2010 390 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:
600-800 IU/day
immunesupport:
1,000-2,000 IU/day
deficiencycorrection:
4,000-5,000 IU/day (under medical supervision)

Üst sınır: 4,000 IU/day (100 mcg)

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
None -- Negative --
2500 IU vitamin D + 1000 mcg B12 -- Positive 124
None -- Negative 72
Single dose (rats); variable (in vitro) -- Positive --
Topical ointment application (3 arms) 8 weeks Positive --
None -- Positive --
None -- Mixed --
None -- Mixed --

En iyi alım zamanı: With a meal containing fat for better absorption

Safety & Side Effects

Bildirilen Yan Etkiler

  • Hypercalcemia at very high doses (nausea, vomiting, weakness)
  • Kidney stones with excessive long-term use
  • Constipation
  • Metallic taste

Bilinen Etkileşimler

  • Thiazide diuretics (may increase risk of hypercalcemia)
  • Corticosteroids (reduce vitamin D absorption and metabolism)
  • Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)
  • Statins (vitamin D may affect statin metabolism)

Tolere edilebilir üst alım: 4,000 IU/day (100 mcg)

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Vitamin D help with Immune Aging (Immunosenescence)?
Based on 10 studies with 5,000 participants, there is moderate evidence from clinical studies that Vitamin D may support Immune Aging (Immunosenescence) management. Our evidence grade is B (Good Evidence).
How much Vitamin D should I take for Immune Aging (Immunosenescence)?
Studies have used various dosages. A commonly studied range is 600-800 IU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness), Kidney stones with excessive long-term use, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and Immune Aging (Immunosenescence)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 5,000 total participants. The overall direction of effect is positive.

Related Evidence

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.